Alphabet's Isomorphic raises $600m for AI drug discovery
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which included more than $80 million upfront, and in February the company announced that Novartis had expanded their alliance, adding three additional research programmes "on the same financial terms as the original agreement."
AlphaFold’s success would pave the way for Isomorphic Labs, a spinoff focused on AI-driven drug discovery. Isomorphic was founded in 2021, but it wasn’t until yesterday that the company ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding within Google parent company Alphabet, raising $600 million to advance its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback